Table 1.
Hh Pathway Target | Effects of Activated Hh Signaling | Suspected Role in MB Tumorigenesis | Effects of Targeted Inhibition |
---|---|---|---|
MYCN60,61 | Increased expression in CGNPs | Induces miR-17/92 expression in CGNPs, promoting their proliferation | Anti–miR-17 and -19 reduced growth of MB tumor allografts (flank and brain) and prolonged survival in mice with intracranial transplants113 |
Snail162 | Increased expression in GCPs, mouse MB models, and human MB-derived cell lines | Induces cell proliferation and transformation through induction of MYCN transcription | |
CXCR453,72 | Induces cell surface localization and effector signaling in MB cells | Causes progrowth transcriptional response (increased expression of Math1/Atoh1 and cyclin D1) and increased tumor growth | CXCR4-specific antagonists, AMD3100 and AMD3465, inhibited growth of MB tumor xenografts |
Sox264 | Increased expression in CGNPs and Sox2-positive MB in mouse models | Overexpression leads to proliferation | Deletion of Sox2 in primary CGNP cultures with constitutive SHH signaling led to decreased proliferation |
Sox965 | Increased expression in SHH MB | Activation during embryogenesis leads to SHH-dependent MB; suppression during postnatal development promotes SHH-independent MB | |
ASPM66 | Increased expression in CGNPs | Sustains the progenitor phenotype of CGNPs | ASPM knock-out led to decreased proliferative capacity and self-renewal |
Bmi169–71 | Drives expression in BTICs | Contributes to SHH-mediated expansion of GCPs through direct regulation of the cyclin-dependent kinase inhibitor p21 Waf1/Cip1 and modulation of other cell cycle inhibitors and TGFβ pathway targets; positive feedback loop between Bmi1 and SHH in BTICs; may regulate the SHH pathway through transcriptional silencing of the E3 ubiquitin ligase Cullin3 | |
Bcl267,68 | Increased expression | Increases proliferation and decreases apoptosis of SHH-induced MB | |
Lipids73 | Lipid accumulation, increased lipogenic enzyme expression, and suppression of fatty acid oxidation | Fatty acid synthase-specific inhibitor C75 inhibited MB cell proliferation, promoted MB cell death, and prolonged survival in MB-bearing mice | |
PPARγ74 | Increased expression in MB cells | Induces glycolysis | PPARγ-specific inhibitor, GW9662, blocked CGNP proliferation, drove MB cell death, and prolonged survival of mice with MBs (NeuroD2-SmoA1) |
Abbreviations: ASPM, abnormal spindle-like microencephaly-associated; Atoh1, atonal homolog 1; BTIC, brain tumor initiating cell; CGNP, cerebellar granule neuron progenitor; GCP, granule cell progenitor; MB, medulloblastoma; MYCN, v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog; PPARγ, peroxisome proliferator-activated receptor gamma; SHH, sonic hedgehog; Sox, sex determining region Y; TFGβ, transforming growth factor beta.